101 results
Page 3 of 6
8-K
EX-99.1
0fg5sovdbewc oxuc
14 Sep 22
Nurix Therapeutics Appoints Leading Industry Strategist Edward C. Saltzman to its Board of Directors
4:01pm
8-K
EX-10.1
razdk ry3efpc4xha
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
8-K
EX-99.1
6sgu5m brnuy
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
8-K
EX-99.2
lmow4 m4vlpvp
8 Jul 22
Nurix Therapeutics Announces $55 Million Registered Direct Offering
4:13pm
424B5
2w2ixzroi
8 Jul 22
Prospectus supplement for primary offering
4:10pm
424B5
7ukhs
8 Jul 22
Prospectus supplement for primary offering
4:09pm
8-K
EX-99.1
ofljgrkdlis0wktae3
7 Jul 22
Nurix Therapeutics Reports Fiscal Second Quarter 2022 Financial Results and Provides a Corporate Update
4:09pm
8-K
EX-99.2
x4at6a1bl e7
26 May 22
Other Events
7:02am
8-K
EX-99.1
4x42aq9zbho0xwv
26 May 22
Other Events
7:02am
8-K
EX-99.1
fnmfw8343wxru
7 Apr 22
Nurix Therapeutics Reports Fiscal First Quarter 2022 Financial Results and Provides a Corporate Update
4:08pm
8-K
EX-99.1
kuh0yh2mqlz1crd a8i
27 Jan 22
Nurix Therapeutics Reports Fourth Quarter and Fiscal Year 2021 Financial Results and Provides a Corporate Update
4:07pm